Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias.
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2014
At a glance
- Drugs Clofarabine (Primary) ; Etoposide; Mitoxantrone
- Indications Leukaemia
- Focus Adverse reactions
- 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov.
- 17 Jan 2014 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as per Clinicaltrials.gov
- 17 Jan 2014 Status changed from suspended to active, no longer recruiting as per Clinicaltrials.gov